Dalili S - Search Results

1

Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligands.

Wood TE, Dalili S, Simpson CD, Sukhai MA, Hurren R, Anyiwe K, Mao X, Suarez Saiz F, Gronda M, Eberhard Y, MacLean N, Ketela T, Reed JC, Moffat J, Minden MD, Batey RA, Schimmer AD. Wood TE, et al. Among authors: dalili s. Mol Cancer Ther. 2010 Jan;9(1):246-56. doi: 10.1158/1535-7163.MCT-09-0495. Epub 2010 Jan 6. Mol Cancer Ther. 2010. PMID: 20053768

2

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death.

Wood TE, Dalili S, Simpson CD, Hurren R, Mao X, Saiz FS, Gronda M, Eberhard Y, Minden MD, Bilan PJ, Klip A, Batey RA, Schimmer AD. Wood TE, et al. Among authors: dalili s. Mol Cancer Ther. 2008 Nov;7(11):3546-55. doi: 10.1158/1535-7163.MCT-08-0569. Mol Cancer Ther. 2008. PMID: 19001437

3

Targeting XIAP for the treatment of malignancy.

Schimmer AD, Dalili S, Batey RA, Riedl SJ. Schimmer AD, et al. Among authors: dalili s. Cell Death Differ. 2006 Feb;13(2):179-88. doi: 10.1038/sj.cdd.4401826. Cell Death Differ. 2006. PMID: 16322751 Review.

4

Targeting the IAP family of caspase inhibitors as an emerging therapeutic strategy.

Schimmer AD, Dalili S. Schimmer AD, et al. Among authors: dalili s. Hematology Am Soc Hematol Educ Program. 2005:215-9. doi: 10.1182/asheducation-2005.1.215. Hematology Am Soc Hematol Educ Program. 2005. PMID: 16304383 Review.

5

A novel diquinolonium displays preclinical anti-cancer activity and induces caspase-independent cell death.

Hurren R, Beheshti Zavareh R, Dalili S, Wood T, Rose D, Chang H, Jamal N, Messner H, Batey RA, Schimmer AD. Hurren R, et al. Among authors: dalili s. Apoptosis. 2008 Jun;13(6):748-55. doi: 10.1007/s10495-008-0209-6. Apoptosis. 2008. PMID: 18415680

6

Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.

Yip KW, Mao X, Au PY, Hedley DW, Chow S, Dalili S, Mocanu JD, Bastianutto C, Schimmer A, Liu FF. Yip KW, et al. Among authors: dalili s. Clin Cancer Res. 2006 Sep 15;12(18):5557-69. doi: 10.1158/1078-0432.CCR-06-0536. Clin Cancer Res. 2006. PMID: 17000693

7

Design and development of cyclohexane-based P,N-ligands for transition metal catalysis.

Caiazzo A, Dalili S, Yudin AK. Caiazzo A, et al. Among authors: dalili s. Org Lett. 2002 Jul 25;4(15):2597-600. doi: 10.1021/ol026249y. Org Lett. 2002. PMID: 12123385

8

N-arylation of aziridines.

Sasaki M, Dalili S, Yudin AK. Sasaki M, et al. Among authors: dalili s. J Org Chem. 2003 Mar 7;68(5):2045-7. doi: 10.1021/jo020696+. J Org Chem. 2003. PMID: 12608835

9

Transition metal-catalyzed synthesis and reactivity of N-alkenyl aziridines.

Dalili S, Yudin AK. Dalili S, et al. Org Lett. 2005 Mar 17;7(6):1161-4. doi: 10.1021/ol050094n. Org Lett. 2005. PMID: 15760164

10

Serum lipid profile in adolescents and adults with acne vulgaris receiving isotretinoin.

Gharaei Nejad K, Darjani A, Alizadeh N, Hakemzadeh ST, Hassanzadeh Rad A, Kazemnejad-Leili E, Ghadarjani R, Eftekhari H, Rafiei R, Dalili S. Gharaei Nejad K, et al. Among authors: dalili s. Caspian J Intern Med. 2024 Sep 7;15(4):659-665. doi: 10.22088/cjim.15.4.659. eCollection 2024 Fall. Caspian J Intern Med. 2024. PMID: 39359443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters